Interestingly, siBRCA1 treatment resulted in significant increase in the expression of cancer stem cell-associated markers including CD44, ALDH1A3, and OCT4, while leading to down-regulation of CD24 (p < 0.0001 for all pair-wise comparisons, Fig. 3B). Here, CD44 is linked to cancer.